National High-Tech Company
Tianjin Century Healthcare Biomedical Engineering Co., Ltd.

Tianjin Century Healthcare Biomedical Engineering Co., Ltd. (hereinafter referred to as "Century Healthcare ") is a Class III high-end medical device manufacturer integrating R&D, production, and sales. Century Healthcare is located in the West District of Tianjin Development Zone with a GMP factory area of 20,000 m². It established 10,000-level clean production workshop, and high-quality scientific research laboratory equipment with dual water production systems for purified and injection water, as well as an air purification system.Century Healthcare takes " innovative ophthalmic materials and optical design " as its strategic scope, covering fields such as intraocular lenses, optometry, and biomaterial collagen. After more than 10 years of relentless efforts, Century Healthcare has been awarded "National High-Tech Company", "Tianjin Gazelle Company", "Tianjin's 'Specialized, Special and New' Small and Medium-sized Company", "Tianjin Strategic Emerging Leading Company", etc. honorary title. Until now, it has established Tianjin Key Laboratory of Innovative Ophthalmic Optical Technology as well as Ophthalmology and Optometry Industry-Education Integration Graduate Workstation.


National High-Tech Company
2008
Incorporation
20,000
Plan area
70
+
Number of patents
5
Wholly-owned subsidiaries
Products
Focusing on core medical technologies , upgrade solution continuously
Core advantages
Provide a full lifecycle ophthalmic diagnosis and treatment solution
The company has nearly 70 top global ophthalmic research and development talents, including 10 PhDs, 30 Masters, more than 30 senior professional titles, and more than 70 patents; The average industry experience of R&D personnel is nearly 10 years. The company has strong independent research and development capabilities and has established long-term strategic partnerships with multiple colleges and research institutes.
Our R&D team is able to quickly respond to market demand and has strong product technology transformation capabilities, enabling us to quickly achieve industrial production and promote it to the market. Our management team highly recognizes corporate culture.
The company has nearly 70 top global ophthalmic research and development talents, including 10 PhDs, 30 Masters, more than 30 senior professional titles, and more than 70 patents; The average industry experience of R&D personnel is nearly 10 years. The company has strong independent research and development capabilities and has established long-term strategic partnerships with multiple colleges and research institutes.
Our R&D team is able to quickly respond to market demand and has strong product technology transformation capabilities, enabling us to quickly achieve industrial production and promote it to the market. Our management team highly recognizes corporate culture.
News
We provide you with the latest news information and take you to learn more about our updates.
深圳物联科技 | 西安科技 | 广州生物 |